M&R Capital Management’s Medtronic MDT Stock Holding History

M&R Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$246K	Sell	2,728 -752	-22%	-$63.3K	0.05%	122
2024 Q2	$274K	Sell	3,480 -89	-2%	-$7.3K	0.07%	111
2024 Q1	$311K	Buy	3,569 +12	+0.3%	+$1.02K	0.08%	103
2023 Q4	$293K	Sell	3,557 -2,176	-38%	-$166K	0.07%	114
2023 Q3	$449K	Buy	5,733 +177	+3%	+$14.8K	0.12%	90
2023 Q2	$490K	Sell	5,556 -25	-0.4%	-$2.15K	0.13%	89
2023 Q1	$450K	Sell	5,581 -257	-4%	-$20.9K	0.13%	92
2022 Q4	$454K	Sell	5,838 -226	-4%	-$18.3K	0.12%	90
2022 Q3	$489K	Sell	6,064 -942	-13%	-$84.7K	0.14%	89
2022 Q2	$628K	Sell	7,006 -417	-6%	-$42.3K	0.16%	82
2022 Q1	$823K	Buy	7,423 +1,073	+17%	+$113K	0.18%	76
2021 Q4	$656K	Sell	6,350 -300	-5%	-$34.7K	0.14%	83
2021 Q3	$833K	Hold	6,650	–	–	0.19%	72
2021 Q2	$825K	Sell	6,650 -50	-0.7%	-$6.28K	0.19%	70
2021 Q1	$791K	Sell	6,700 -100	-1%	-$11.7K	0.2%	71
2020 Q4	$796K	Sell	6,800 -450	-6%	-$49.5K	0.18%	80
2020 Q3	$753K	Sell	7,250 -100	-1%	-$10K	0.19%	86
2020 Q2	$673K	Hold	7,350	–	–	0.18%	88
2020 Q1	$662K	Sell	7,350 -100	-1%	-$10.6K	0.2%	91
2019 Q4	$844K	Sell	7,450 -1,223	-14%	-$134K	0.19%	92
2019 Q3	$942K	Sell	8,673 -100	-1%	-$10.4K	0.22%	89
2019 Q2	$854K	Sell	8,773 -200	-2%	-$18.3K	0.19%	95
2019 Q1	$783K	Hold	8,973	–	–	0.18%	99
2018 Q4	$816K	Sell	8,973 -216	-2%	-$20.2K	0.21%	90
2018 Q3	$903K	Sell	9,189 -377	-4%	-$34.9K	0.2%	95
2018 Q2	$818K	Sell	9,566 -862	-8%	-$72K	0.19%	101
2018 Q1	$836K	Sell	10,428 -950	-8%	-$78.4K	0.19%	95
2017 Q4	$918K	Sell	11,378 -1,872	-14%	-$150K	0.21%	94
2017 Q3	$1.03M	Sell	13,250 -1,164	-8%	-$96.6K	0.25%	83
2017 Q2	$1.21M	Buy	14,414 +2,704	+23%	+$228K	0.3%	64
2017 Q1	$943K	Sell	11,710 -527	-4%	-$41.2K	0.24%	85
2016 Q4	$871K	Buy	12,237 +1,173	+11%	+$92.2K	0.24%	86
2016 Q3	$955K	Buy	11,064 +74	+0.7%	+$6.45K	0.27%	80
2016 Q2	$953K	Buy	10,990 +450	+4%	+$36.4K	0.28%	80
2016 Q1	$790K	Sell	10,540 -200	-2%	-$15.1K	0.24%	86
2015 Q4	$826K	Hold	10,740	–	–	0.24%	83
2015 Q3	$719K	Sell	10,740 -1,623	-13%	-$120K	0.2%	91
2015 Q2	$916K	Sell	12,363 -669	-5%	-$51.1K	0.22%	86
2015 Q1	$1.02M	Buy	13,032 +5,063	+64%	+$384K	0.24%	79
2014 Q4	$575K	Hold	7,969	–	–	0.14%	113
2014 Q3	$494K	Sell	7,969 -200	-2%	-$12.7K	0.12%	128
2014 Q2	$521K	Sell	8,169 -50	-0.6%	-$3.04K	0.12%	122
2014 Q1	$506K	Sell	8,219 -500	-6%	-$29.1K	0.12%	118
2013 Q4	$500	Sell	8,719 -100	-1%	-$5.67K	0.13%	118
2013 Q3	$470K	Sell	8,819 -100	-1%	-$5.38K	0.13%	117
2013 Q2	$459K	Buy	+8,919	New	+$441K	0.13%	109

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

M&R Capital Management's MDT Position: Q3 2024 in Review

M&R Capital Management reduced its Medtronic (MDT) stake by 22% in Q3 2024, selling an estimated $63.3K and leaving 2,728 shares worth $246K. The position accounts for 0.05% of the portfolio, ranked #122.

M&R Capital Management first reported a position in MDT in Q2 2013 and has held it in 46 quarters since. The position peaked at $1.21M in Q2 2017. 2,064 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

M&R Capital Management held 2,728 shares of Medtronic worth $246K as of Q3 2024.
M&R Capital Management sold 752 Medtronic shares in Q3 2024, an estimated $63.3K.
Medtronic made up 0.05% of M&R Capital Management's portfolio in Q3 2024, its #122 holding.
M&R Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 46 quarters since.
M&R Capital Management's Medtronic position peaked at $1.21M in Q2 2017.
2,064 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on M&R Capital Management's 13F filing for Q3 2024, filed 2 Oct 2024.